Kalaris Therapeutics Inc
KLRS
NASDAQ
Biotechnology
$4.08
USD
+0.20 (+5.15%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $84.74M
Volume 28.1K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ICCC | ImmuCell Corp | $100.42M | - | +9.6% | - | |
GANX | Gain Therapeutics Inc | $94.49M | - | - | - | |
RLYB | Rallybio Corp | $90.07M | - | +1.2% | - | |
ALDX | Aldeyra Therapeutics Inc | $86.87M | - | - | - | |
ATRA | Atara Biotherapeutics Inc | $85.42M | - | -96.7% | - | |
KLRS | Kalaris Therapeutics Inc | $84.74M | - | - | - | |
FRMM | Forum Markets, Inc | $82.43M | - | - | - | |
ACRV | Acrivon Therapeutics Inc | $74.48M | - | - | - | |
CTOR | Citius Oncology Inc | $68.57M | - | - | - |
Top Peer by Growth
ImmuCell Corp
+9.6% YoY Revenue
Best 1-Year Return
Rallybio Corp
+296.3% Return